S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The Elites Are Waging War on Elon Musk — Here's Why… (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
NASDAQ:FUSN

Fusion Pharmaceuticals (FUSN) News Today

$2.60
-0.04 (-1.52%)
(As of 09/29/2023 ET)
Compare
Today's Range
$2.35
$2.81
50-Day Range
$2.37
$3.75
52-Week Range
$1.98
$5.63
Volume
107,908 shs
Average Volume
32,752 shs
Market Capitalization
$179.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.20
SourceHeadline
MarketBeat logoFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $9.50 Average Target Price from Analysts
americanbankingnews.com - October 1 at 1:22 AM
msn.com logoOppenheimer Initiates Coverage of Fusion Pharmaceuticals (FUSN) with Outperform Recommendation
msn.com - September 30 at 2:44 PM
MarketBeat logoOppenheimer Initiates Coverage on Fusion Pharmaceuticals (NASDAQ:FUSN)
americanbankingnews.com - September 30 at 1:40 AM
finance.yahoo.com logoFusion Pharmaceuticals to Present at Upcoming September Investor Conferences
finance.yahoo.com - September 5 at 8:28 PM
msn.com logoRaymond James Maintains Fusion Pharmaceuticals (FUSN) Outperform Recommendation
msn.com - August 29 at 3:20 AM
finance.yahoo.com logo10 Oversold Penny Stocks To Buy
finance.yahoo.com - August 14 at 9:37 AM
markets.businessinsider.com logoFusion Pharmaceuticals (FUSN) Gets a Buy from Truist Financial
markets.businessinsider.com - August 13 at 11:36 PM
marketbeat.com logoQ3 2023 EPS Estimates for Fusion Pharmaceuticals Inc. Raised by Wedbush (NASDAQ:FUSN)
marketbeat.com - August 11 at 9:21 AM
marketbeat.com logoFederated Hermes Inc. Buys 2,625,000 Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)
marketbeat.com - August 11 at 5:51 AM
marketbeat.com logoFusion Pharmaceuticals Inc. to Post Q2 2024 Earnings of ($0.28) Per Share, Wedbush Forecasts (NASDAQ:FUSN)
marketbeat.com - August 10 at 9:33 AM
finance.yahoo.com logoFusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 8 at 12:29 PM
finance.yahoo.com logoFusion Pharmaceuticals Announces Second Quarter 2023 Financial Results and Clinical Program Updates
finance.yahoo.com - August 8 at 7:29 AM
marketbeat.com logoFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Rating of "Buy" by Brokerages
marketbeat.com - August 7 at 5:31 AM
marketbeat.com logoFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Rating of "Buy" by Analysts
marketbeat.com - July 13 at 4:20 AM
marketbeat.com logoFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Short Interest Update
marketbeat.com - June 30 at 7:44 PM
msn.com logoWedbush Reiterates Fusion Pharmaceuticals (FUSN) Outperform Recommendation
msn.com - June 29 at 6:19 PM
finance.yahoo.com logoOne Fusion Pharmaceuticals Insider Raised Stake By 370% In Previous Year
finance.yahoo.com - June 29 at 1:18 PM
markets.businessinsider.com logoB.Riley Financial Sticks to Their Buy Rating for Fusion Pharmaceuticals (FUSN)
markets.businessinsider.com - June 29 at 8:18 AM
markets.businessinsider.com logoJonesTrading Sticks to Their Buy Rating for Fusion Pharmaceuticals (FUSN)
markets.businessinsider.com - June 28 at 2:46 PM
finance.yahoo.com logoFusion Pharmaceuticals to Present Interim Data from Phase 1 Trial of FPI-1434 in Patients with Solid Tumors Expressing IGF-1R
finance.yahoo.com - June 26 at 8:33 AM
nasdaq.com logoRaymond James Initiates Coverage of Fusion Pharmaceuticals (FUSN) with Outperform Recommendation
nasdaq.com - June 24 at 1:39 PM
marketbeat.com logoFusion Pharmaceuticals (NASDAQ:FUSN) Earns Outperform Rating from Analysts at Raymond James
marketbeat.com - June 23 at 9:08 AM
marketbeat.com logoFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Average Rating of "Buy" by Analysts
marketbeat.com - June 18 at 4:26 AM
markets.businessinsider.com logoB.Riley Financial Keeps Their Buy Rating on Fusion Pharmaceuticals (FUSN)
markets.businessinsider.com - June 16 at 9:06 AM
finance.yahoo.com logoFusion Pharmaceuticals to Present at the TD Cowen Radiopharmaceutical Innovation Summit
finance.yahoo.com - June 16 at 9:06 AM
baystreet.ca logoFusion Announces Inducement
baystreet.ca - June 7 at 2:43 PM
finance.yahoo.com logoFusion Pharmaceuticals to Present at the Jefferies Healthcare Conference
finance.yahoo.com - May 31 at 6:49 PM
finance.yahoo.com logoThese 2 “Strong Buy” Penny Stocks Could Surge 200% (or More), Says Wedbush
finance.yahoo.com - May 31 at 1:49 PM
marketbeat.com logoFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Consensus Recommendation of "Buy" from Brokerages
marketbeat.com - May 24 at 4:45 AM
markets.businessinsider.com logoSVB Securities Sticks to Their Buy Rating for Fusion Pharmaceuticals (FUSN)
markets.businessinsider.com - May 15 at 9:21 AM
marketbeat.com logoEquities Analysts Offer Predictions for Fusion Pharmaceuticals Inc.'s FY2027 Earnings (NASDAQ:FUSN)
marketbeat.com - May 15 at 4:38 AM
msn.com logoRecap: Fusion Pharmaceuticals Q1 Earnings
msn.com - May 12 at 8:41 AM
markets.businessinsider.com logoJonesTrading Sticks to Its Buy Rating for Fusion Pharmaceuticals (FUSN)
markets.businessinsider.com - May 12 at 8:41 AM
finance.yahoo.com logoFusion Pharmaceuticals First Quarter 2023 Earnings: Misses Expectations
finance.yahoo.com - May 12 at 8:41 AM
finance.yahoo.com logoFusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updates
finance.yahoo.com - May 11 at 7:36 AM
finance.yahoo.com logoFusion Pharmaceuticals Inc. (NASDAQ:FUSN) has caught the attention of institutional investors who hold a sizeable 34% stake
finance.yahoo.com - May 10 at 10:02 AM
finance.yahoo.com logoFusion Pharmaceuticals to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day
finance.yahoo.com - May 9 at 8:59 AM
finance.yahoo.com logoFusion Pharmaceuticals Announces Opening of Radiopharmaceutical Manufacturing Facility to Produce Targeted Alpha Therapies for Cancer
finance.yahoo.com - May 2 at 5:43 PM
seekingalpha.com logoFUSN Fusion Pharmaceuticals Inc.
seekingalpha.com - April 20 at 7:20 PM
finance.yahoo.com logoFusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2059 and Leading Targeted Alpha Therapy Platform at AACR Annual Meeting
finance.yahoo.com - April 19 at 5:53 PM
marketbeat.com logoQ1 2023 Earnings Forecast for Fusion Pharmaceuticals Inc. Issued By B. Riley (NASDAQ:FUSN)
marketbeat.com - April 3 at 1:39 AM
marketbeat.com logoFusion Pharmaceuticals' (FUSN) Buy Rating Reiterated at B. Riley
marketbeat.com - March 31 at 8:36 AM
finance.yahoo.com logoFusion Pharmaceuticals Announces First Patient Dosed in Phase 1 Study of FPI-2059, a Targeted Alpha Therapy (TAT) for the Treatment of Solid Tumors Expressing NTSR1
finance.yahoo.com - March 20 at 7:42 PM
benzinga.com logoFusion Pharmaceuticals Earnings Perspective: Return On Capital Employed
benzinga.com - March 20 at 2:25 PM
marketbeat.com logoAnalysts Issue Forecasts for Fusion Pharmaceuticals Inc.'s Q1 2024 Earnings (NASDAQ:FUSN)
marketbeat.com - March 20 at 2:12 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Fusion Pharmaceuticals (FUSN) and ATI Physical Therapy (ATIP)
markets.businessinsider.com - March 17 at 10:13 AM
finanznachrichten.de logoFusion Pharmaceuticals Inc.: Fusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results and Clinical Program Updates
finanznachrichten.de - March 16 at 12:13 PM
finance.yahoo.com logoFusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results and Clinical Program Updates
finance.yahoo.com - March 16 at 12:13 PM
finance.yahoo.com logoFusion Pharmaceuticals Inc. (FUSN) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - March 16 at 12:13 PM
marketbeat.com logoShort Interest in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Declines By 66.7%
marketbeat.com - March 10 at 6:53 PM
Get Fusion Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for FUSN and its competitors with MarketBeat's FREE daily newsletter.



FUSN Media Mentions By Week

FUSN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FUSN
News Sentiment

0.31

0.70

Average
Medical
News Sentiment

FUSN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FUSN Articles
This Week

6

1

FUSN Articles
Average Week

Get Fusion Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for FUSN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:FUSN) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -